GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Works Technologies AB (XSAT:BIOWKS) » Definitions » PE Ratio (TTM)

Bio-Works Technologies AB (XSAT:BIOWKS) PE Ratio (TTM) : At Loss (As of Apr. 08, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Bio-Works Technologies AB PE Ratio (TTM)?

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2025-04-08), Bio-Works Technologies AB's share price is kr1.09. Bio-Works Technologies AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was kr-0.29. Therefore, Bio-Works Technologies AB's PE Ratio (TTM) for today is At Loss.


The historical rank and industry rank for Bio-Works Technologies AB's PE Ratio (TTM) or its related term are showing as below:

XSAT:BIOWKS' s PE Ratio (TTM) Range Over the Past 10 Years
Min: At Loss   Med: At Loss   Max: At Loss
Current: At Loss



XSAT:BIOWKS's PE Ratio (TTM) is ranked worse than
100% of 259 companies
in the Biotechnology industry
Industry Median: 28.05 vs XSAT:BIOWKS: At Loss

Bio-Works Technologies AB's Earnings per Share (Diluted) for the three months ended in Dec. 2024 was kr-0.17. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was kr-0.29.

As of today (2025-04-08), Bio-Works Technologies AB's share price is kr1.09. Bio-Works Technologies AB's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was kr-0.29. Therefore, Bio-Works Technologies AB's PE Ratio without NRI for today is At Loss.

Bio-Works Technologies AB's EPS without NRI for the three months ended in Dec. 2024 was kr-0.17. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was kr-0.29.

During the past 3 years, the average EPS without NRI Growth Rate was -36.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was -2.90% per year.

During the past 10 years, Bio-Works Technologies AB's highest 3-Year average EPS without NRI Growth Rate was 40.70% per year. The lowest was -47.00% per year. And the median was -14.80% per year.

Bio-Works Technologies AB's EPS (Basic) for the three months ended in Dec. 2024 was kr-0.17. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was kr-0.29.


Bio-Works Technologies AB PE Ratio (TTM) Historical Data

The historical data trend for Bio-Works Technologies AB's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Works Technologies AB PE Ratio (TTM) Chart

Bio-Works Technologies AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PE Ratio (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Bio-Works Technologies AB Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Competitive Comparison of Bio-Works Technologies AB's PE Ratio (TTM)

For the Biotechnology subindustry, Bio-Works Technologies AB's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Works Technologies AB's PE Ratio (TTM) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Works Technologies AB's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where Bio-Works Technologies AB's PE Ratio (TTM) falls into.


;
;

Bio-Works Technologies AB PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Bio-Works Technologies AB's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=1.09/-0.290
=At Loss

Bio-Works Technologies AB's Share Price of today is kr1.09.
Bio-Works Technologies AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.29.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Bio-Works Technologies AB  (XSAT:BIOWKS) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


Bio-Works Technologies AB PE Ratio (TTM) Related Terms

Thank you for viewing the detailed overview of Bio-Works Technologies AB's PE Ratio (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Works Technologies AB Business Description

Traded in Other Exchanges
Address
Virdings alle 18, Uppsala, SWE, 75450
Bio-Works Technologies AB is a Sweden-based life science company which is engaged in designing, developing, manufacturing and supplying products for purification and separation of proteins and other molecules. The product line of the company includes activated resin, immobilized metal-ion affinity chromatography resin, ion exchange chromatography resin, size exclusion chromatography resin and others. The company has also developed affinity chromatography technique, BabyBio Columns, OptiBio glass columns for separating proteins, and protein purification. Bio-Works serves various end users such as academic research laboratories, biopharmaceutical companies, the food and beverage industry and others.

Bio-Works Technologies AB Headlines

No Headlines